Zobrazeno 1 - 10
of 389
pro vyhledávání: '"Axel Dignass"'
Autor:
Alessandro Armuzzi, Ailsa Hart, Joseph C. Cappelleri, Nadir Mammar, Peter Hur, Benjamin Hoskin, Fritha Hennessy, Gary Milligan, Axel Dignass
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background To describe variations in treatment patterns, clinical outcomes, patient-reported outcomes (PRO), and physician and patient satisfaction in patients with moderate-to-severe ulcerative colitis (UC) treated with tofacitinib in a rea
Externí odkaz:
https://doaj.org/article/3484e9af9b88449bb7f7467af1130a07
Autor:
Fernando Magro, Catarina Sottomayor, Catarina Alves, Mafalda Santiago, Paula Ministro, Paula Lago, Luís Correia, Raquel Gonçalves, Diana Carvalho, Francisco Portela, Cláudia Camila Dias, Axel Dignass, Silvio Danese, Laurent Peyrin-Biroulet, Maria Manuela Estevinho, Paula Leão Moreira
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: This systematic review and meta-analysis aims to assess composite and aggregate outcomes of observational studies in Crohn’s disease and to evaluate whether the number and type of variables included affect the frequency of the outcome.
Externí odkaz:
https://doaj.org/article/73fa1f57553f49dcaf5ce9beeb4b11ac
Autor:
Bénédicte Caron, Vipul Jairath, Ferdinando D’Amico, Sameer Al Awadhi, Axel Dignass, Ailsa L. Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
Publikováno v:
Medicina, Vol 59, Iss 1, p 183 (2023)
Background and Objectives: At present, there is no consensus definition of mild-to-moderate disease activity in patients with ulcerative colitis. The objective of the present study was to establish a reliable definition of mild-to-moderate disease ac
Externí odkaz:
https://doaj.org/article/7084dc964d414d2a925b15b511cafcce
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2629 (2008)
Galectin-4 is a carbohydrate-binding protein belonging to the galectin family. Here we provide novel evidence that galectin-4 is selectively expressed and secreted by intestinal epithelial cells and binds potently to activated peripheral and mucosal
Externí odkaz:
https://doaj.org/article/d4ec619590404c6ebbd9011ac2f5f005
Autor:
Fernando Magro, Paula Leão Moreira, Gaia Catalano, Catarina Alves, Joana Roseira, Maria Manuela Estevinho, Isabel Silva, Axel Dignass, Laurent Peyrin‐Biroulet, Silvio Danese, Vipul Jairath, Claudia Camila Dias, Mafalda Santiago
Publikováno v:
United European Gastroenterology Journal. 11:202-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::606ec9078a12f12e99fb398344b6dd80
https://doi.org/10.1002/ueg2.12366
https://doi.org/10.1002/ueg2.12366
Autor:
Bélène Podmore, Dominik Beier, Johan Burisch, Elisabeth Genestin, Dennis Haeckl, Oliver Nagel, Nawab Qizilbash, David A. Schwartz, Stephan R. Vavricka, Dimitri Bennett, Axel Dignass
Publikováno v:
United European Gastroenterology Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ac3117ea47db63d26533ad4dcd90400
https://doi.org/10.1002/ueg2.12396
https://doi.org/10.1002/ueg2.12396
Autor:
Lucas Guillo, Maria Abreu, Remo Panaccione, William J Sandborn, Valderilio F Azevedo, Lianne Gensler, Bahar Moghaddam, Vineet Ahuja, Sabrina A Ali, Matthieu Allez, Ashwin N Ananthakrishnan, Abhik Bhattacharya, Marla Dubinsky, Anne Griffiths, Ailsa Hart, Burton Korelitz, Paulo G Kotze, Ioannis E Koutroubakis, Peter L Lakatos, James O Lindsay, Fernando Magro, Gerassimos J Mantzaris, Siew C Ng, Colm O'Morain, Julian Panés, Tommaso Parigi, Zhihua Ran, Gerhard Rogler, David T Rubin, David B Sachar, Britta Siegmund, Flavio Steinwurz, Curt Tysk, Stephan Vavricka, Sofia G Verstraete, Antoine P Brezin, Anna K Haemel, Axel Dignass, Bruce E Sands, Silvio Danese, Laurent Peyrin-Biroulet
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:254-261
Extraintestinal manifestations occur frequently in patients with inflammatory bowel disease (IBD) and remain a diagnostic and therapeutic challenge. The aim of the Endpoints for Extraintestinal Manifestations in Inflammatory Bowel Disease Trials (EXT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803619801073a456b84fbe5824bfe63e
https://doi.org/10.1016/s2468-1253(21)00297-1
https://doi.org/10.1016/s2468-1253(21)00297-1
Autor:
Marte Lie Høivik, Paulo Gustavo Kotze, Laurent Peyrin-Biroulet, Axel Dignass, Stephan R. Vavricka, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Fernando Magro, Paula Sousa, Rogerio Saad-Hossne, Paula Ministro
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2022-04-29T08:30:08Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01 Background and aims: The role of thiopurines in therapeutic algorithms of Crohn's disease (CD) and Ulcerative colitis (UC) is being questione
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ace00c1c0088c1ae0f5d6d707133e1
https://doi.org/10.1016/j.dld.2021.05.038
https://doi.org/10.1016/j.dld.2021.05.038
Autor:
Dotan Yogev, Bram Verstockt, Axel Dignass, Gili Focht, Ohad Atia, Iris Dotan, Severine Vermeire, Dan Turner
Publikováno v:
Inflammatory bowel diseases.
Lay Summary The Mucosal Inflammation Noninvasive Index is a validated noninvasive tool to assess endoscopic remission in pediatric Crohn’s disease. In this study, we evaluated a modified version of the Mucosal Inflammation Noninvasive Index on adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c35db6b95d1745022a05d8d6c958529
https://pubmed.ncbi.nlm.nih.gov/36350981
https://pubmed.ncbi.nlm.nih.gov/36350981
Autor:
Joana Roseira, Mafalda Santiago, Maria Manuela Estevinho, Paula Moreira, Catarina Alves, Silvio Danese, Laurent Peyrin-Biroulet, Axel Dignass, Roger Feakins, Fernando Magro
Publikováno v:
Inflammatory bowel diseases.
Background The effectiveness of Crohn’s disease treatments for inducing histological outcomes has not been addressed systematically. We performed a systematic review and meta-analysis of randomized controlled trials in Crohn’s disease to assess t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79781724af79693aa869b456ea507156
https://pubmed.ncbi.nlm.nih.gov/36250778
https://pubmed.ncbi.nlm.nih.gov/36250778